New user?
Register Now
From June 19th to 21st, the 22nd CPHI China 2024 was held at the Shanghai New International Expo Center.
This exhibition has expanded to 26 exhibition halls, with a display area of over 210000 square meters. Nearly 3500 companies representing the pioneering innovation force of China's pharmaceutical industry showcased on the same stage, sharing research results and cutting-edge technologies, leading the new direction of the industry in the future, and providing strong support for the industrialization of pharmaceutical innovative products and the internationalization of domestic innovative drugs. FDC made its debut at this conference and showcased the company's latest innovative research and development achievements.
Since its establishment in 2010, FDC has been committed to providing high-quality and cost-effective small molecule chemical drug CRO&CDMO services to global customers, with rich experience.
At present, FDC's research and development achievements in the field of small molecule innovative drugs have been recognized by global partners. FDC hopes to utilize the exhibition platform of CPHI to further expand domestic and international markets, and establish long-term and stable strategic partnerships with more partners.
